Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지

Clinical and Phylogenetic Characteristics of Escherichia coli Urinary Tract Infections

대장균에 의한 요로감염의 연령별, 계통군별 특징

  • Lee, Ji Eun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Lee, Youn Hee (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Nam, Chan Hee (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Kwak, Ga Young (Department of Pediatrics, Changwon Fatima Hospital) ;
  • Lee, Soo Young (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Kim, Jong Hyun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Hur, Jae Kyun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Kang, Jin Han (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
  • 이지은 (가톨릭대학교 의과대학 소아과학교실) ;
  • 이윤희 (가톨릭대학교 의과대학 소아과학교실) ;
  • 남찬희 (가톨릭대학교 의과대학 소아과학교실) ;
  • 곽가영 (창원파티마병원 소아청소년과) ;
  • 이수영 (가톨릭대학교 의과대학 소아과학교실) ;
  • 김종현 (가톨릭대학교 의과대학 소아과학교실) ;
  • 허재균 (가톨릭대학교 의과대학 소아과학교실) ;
  • 강진한 (가톨릭대학교 의과대학 소아과학교실)
  • Received : 2009.11.11
  • Accepted : 2009.12.28
  • Published : 2010.06.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : We aimed to investigate the clinical and phylogenetic characteristics of Escherichia coli Urinary Tract Infections (E. coli UTI). Methods : We enrolled patients with culture-proven E. coli UTI, who were admitted at the study hospital from September 2008 to August 2009. We investigated clinical data of patients with E. coli UTI and characteristics of isolated E. coli strains. The phylogenetic groups were classified using triplex polymerase chain reaction (PCR), and the distribution of nine virulent genes was determined by multiplex PCR. Results : A total of 47 patients have participated in this study. Thirty (63.8%) were under 6 months; eight (17.0%) were between 6-12 months; and nine (19.1%) were over 12 months. We compared two age groups between under 6-month and over 6-month. In the age group under 6-month, higher proportion of male (P =0.002) and group B2 strains (P =0.020) were observed. In contrast, higher proportion of female and group non-B2 strains were observed in age group over 6-month. Frequencies of papC, papGII, papGIII, sfa/foc, hlyC, cnf1, fyuA, iroN and iucC were estimated as 68.1%, 57.4%, 42.6%, 46.8%, 46.8%, 31.9%, 87.2%, 48.9% and 63.8%, respectively. In the comparison of phylogenetic groups, group B2 showed higher distribution of virulent genes, while group D included more strains resistant to trimethoprim/sulfamethoxazole (TMP/SMZ) than other groups. Conclusion : We showed the age group-specific difference in the distribution of sex ratios and phylogenetic groups; more male and group B2 strains in age group under 6-month, while more female and group non-B2 in age group over 6-month. However, further evaluation including larger number of patients will be necessary to confirm above thesis in future molecular epidemiological studies.

목 적:E. coli UTI의 임상양상과 UPEC의 미생물학적 특징을 확인하여 연령별, 계통군별 연관성을 평가하고자 하였다. 방 법: 2008년 9월부터 2009년 8월까지 요로감염으로 입원하여 배양검사에서 E. coli가 검출된 환아를 대상으로 하였다. 환자의 임상양상과 검사소견을 확인하였고, 검출된 E. coli를 계통학적으로 분류하고 독성유전자의 분포와 항생제 내성률을 조사하였다. 결 과:총 47명의 E. coli UTI 환아가 연구에 참여하였다. 연령군별로 6개월 미만 30명(63.8%), 6-12개월은 8명(17.0 %), 12개월 이상 9명(19.1%)이었다. 6개월 미만 연령군에는 남아(70.0%)가 많았고 6개월 이상연령군에는 여아(76.5%)가 많았다(P =0.002). 계통학적 분석에서 UPEC의 대부분(80.8%)은 B2 혹은 D군에 속하였다. 연령군별로는 6개월 미만 연령군에는 B2군(80.0%)가 많았고 6개월이상연령군에는non-B2군(52.9%)가 많았다(P=0.020). 계통군별로는 B2군에는 몇몇 독성유전자의 높은 분포가 확인되었고(P <0.05), D군에는 TMP/SMX에 내성을 보이는 균주들이 높은 빈도로 포함되었다(P =0.031). 결 론:E. coli UTI 환아 중 6개월 미만과 6개월 이상 연령군은 남녀비와 계통군의 분포 차이를 보였다. 즉, 6개월 미만 연령군에는 남아와 B2군의 분포가 높았고, 6개월 이상 연령군에는 여아와 non-B2군의 분포가 높았다. 연령별 계통군의 분포 차이는 향후 연구를 통해 검증이 필요할 것이다.

Keywords

References

  1. Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 2008;27:302-8. https://doi.org/10.1097/INF.0b013e31815e4122
  2. Elder JS. Urologic disorders in infants and children. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BE, editors. Nelson Textbook of Pediatrics. 18th ed. Philadelphia : WB Saunders Co, 2007:2223-8.
  3. Herz AM, Greenhow TL, Alcantara J, Hansen J, Baxter RP, Black SB, et al. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J 2006;25:293-300. https://doi.org/10.1097/01.inf.0000207485.39112.bf
  4. Johnson JR, Owens KL, Clabots CR, Weissman SJ, Cannon SB. Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis. Microbes Infect 2006; 8:1702-13. https://doi.org/10.1016/j.micinf.2006.02.007
  5. Duriez P, Clermont O, Bonacorsi S, Bingen E, Chaventré A, Elion J, et al. Commensal Escherichia coli isolates are phylogenetically distinct human populations. Microbiology 2001;147:1671-6. https://doi.org/10.1099/00221287-147-6-1671
  6. Baldy-Chudzik K, Mackiewicz P, Stosik M. Phylogenetic background, virulence gene profiles, and genomic diversity in commensal Escherichia coli isolated from ten mammal species living in one zoo. Vet Microbiol 2008;131:173- 84. https://doi.org/10.1016/j.vetmic.2008.02.019
  7. Orsi RH, Stoppe NC, Sato MI, Ottoboni LM. Identification of Escherichia coli from groups A, B1, B2 and D in drinking water in Brazil. J Water Health 2007;5: 323-7. https://doi.org/10.2166/wh.2007.028
  8. Houdouin V, Bonacorsi S, Mahjoub-Messai F, Mariani- Kurkdjian P, Bidet P, Sebag G, et al. Phylogenetic groups and virulence factors of Escherichia coli strains causing pyelonephritis in children with and without urinary tract abnormalities. Clin Microbiol Infect 2007;13:740-2. https://doi.org/10.1111/j.1469-0691.2007.01748.x
  9. Herzer PJ, Inouye S, Inouye M, Whittam TS. Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol 1990;172:6175-81. https://doi.org/10.1128/jb.172.11.6175-6181.1990
  10. Rijavec M, Starcic Erjavec M, Ambrozic Avgustin J, Reissbrodt R, Fruth A, Krizan-Hergouth V, et al. High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Curr Microbiol 2006;53:158-62. https://doi.org/10.1007/s00284-005-0501-4
  11. Russo TA, Johnson JR. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis 2000;181:1753-4. https://doi.org/10.1086/315418
  12. Russo TA, Beanan JM, Olson R, Genagon SA, Mac- Donald U, Cope JJ, et al. A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate. Vaccine 2007;25: 3859-70. https://doi.org/10.1016/j.vaccine.2007.01.100
  13. Durant L, Metais A, Soulama-Mouze C, Genevard JM, Nassif X, Escaich S. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli. Infect Immun 2007;75:1916-25. https://doi.org/10.1128/IAI.01269-06
  14. Yoo KH, Cho JJ, Lee SJ. Characterization of uropathogenic Escherichia coli. Korean J UTII 2007;2:61-5.
  15. Cheng CH, Tsau YK, Lin TY. Effective duration of antimicrobial therapy for the treatment of acute lobar nephronia. Pediatrics 2006;117:e84-9. https://doi.org/10.1542/peds.2005-0917
  16. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555-8. https://doi.org/10.1128/AEM.66.10.4555-4558.2000
  17. Le Bouguenec C, Archambaud M, Labigne A. Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol 1992; 30:1189-93.
  18. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000;181:261-72. https://doi.org/10.1086/315217
  19. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifth informational supplement, M100-S15. Wayne, PA: CLSI, 2005.
  20. Johnson JR, Russo TA. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 2005;295:383-404. https://doi.org/10.1016/j.ijmm.2005.07.005
  21. Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobialsusceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J Infect Dis 2004; 190:1739-44. https://doi.org/10.1086/425018
  22. Grude N, Potaturkina-Nesterova NI, Jenkins A, Strand L, Nowrouzian FL, Nyhus J, et al. A comparison of phylogenetic group, virulence factors and antibiotic resistance in Russian and Norwegian isolates of Escherichia coli from urinary tract infection. Clin Microbiol Infect 2007;13:208-11. https://doi.org/10.1111/j.1469-0691.2006.01584.x
  23. Randolph MF, Majors F. Office screening for bacteriuria in early infancy: collection of a suitable urine specimen. J Pediatr 1970;76:934-6. https://doi.org/10.1016/S0022-3476(70)80380-8
  24. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001;345:1007-13. https://doi.org/10.1056/NEJMoa011265
  25. Bingen-Bidois M, Clermont O, Bonacorsi S, Terki M, Brahimi N, Loukil C. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect Immun 2002;70: 3216-26. https://doi.org/10.1128/IAI.70.6.3216-3226.2002